{
    "pmcid": "10165273",
    "qa_pairs": {
        "How can AlphaFold-Multimer's predictions be applied to SARS-CoV-2 nanobody design?": [
            "By modeling potential interactions between nanobodies and the spike protein to identify promising candidates.",
            "By predicting the genetic sequence of the SARS-CoV-2 spike protein.",
            "By simulating the immune response to SARS-CoV-2 infection.",
            "By designing vaccines targeting the SARS-CoV-2 nucleocapsid protein."
        ],
        "What is a general role of AlphaFold-Multimer beyond GPCR studies?": [
            "Understanding complex protein interactions essential for drug discovery and development.",
            "Predicting the metabolic pathways in liver diseases.",
            "Analyzing the genetic mutations in viral genomes.",
            "Designing small molecules for cancer therapy."
        ],
        "What is the primary focus of the interaction explored in the study involving MRGPRX4?": [
            "The interaction between MRGPRX4 and receptor activity-modifying proteins (RAMPs), particularly RAMP2.",
            "The interaction between MRGPRX4 and the SARS-CoV-2 spike protein.",
            "The interaction between MRGPRX4 and cholestatic itch receptors.",
            "The interaction between MRGPRX4 and liver disease biomarkers."
        ],
        "What structural feature does the AlphaFold-Multimer prediction include for the MRGPRX4-RAMP2 complex?": [
            "A disulfide bond between TM4 and TM5.",
            "A hydrogen bond network between TM1 and TM2.",
            "A salt bridge between the extracellular loops.",
            "A covalent bond between the intracellular domains."
        ],
        "Which computational tool is used to predict the structure of the MRGPRX4-RAMP2 complex?": [
            "AlphaFold-Multimer.",
            "RosettaDock.",
            "Molecular Dynamics Simulations.",
            "Cryo-EM."
        ]
    }
}